Retinoic Acid Receptor beta antibody
Quick Overview for Retinoic Acid Receptor beta antibody (ABIN7882159)
Target
See all Retinoic Acid Receptor beta (RARB) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- RARB Antibody / Retinoic Acid Receptor beta
-
Purification
- Affinity purified
-
Immunogen
- A synthetic peptide specific to human Retinoic Acid Receptor beta / RARB was used as the immunogen for the RARB antibody.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal dilution of the RARB antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Antibody in PBS with 0.02 % sodium azide, 50 % glycerol and 0.4-0.5 mg/mL BSA
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store the RARB antibody at -20oC.
-
-
- Retinoic Acid Receptor beta (RARB) (Retinoic Acid Receptor, beta (RARB))
-
Alternative Name
- RARB
-
Background
- The RARB gene encodes retinoic acid receptor beta, a member of the thyroid-steroid hormone receptor superfamily of nuclear transcriptional regulators. This receptor localizes to the cytoplasm and to subnuclear compartments. It binds retinoic acid, the biologically active form of vitamin A which mediates cellular signalling in embryonic morphogenesis, cell growth and differentiation. It is thought that this protein limits growth of many cell types by regulating gene expression. The gene was first identified in a hepatocellular carcinoma where it flanks a hepatitis B virus integration site. Alternate promoter usage and differential splicing result in multiple transcript variants. [RefSeq]
-
UniProt
- P10826
-
Pathways
- Nuclear Receptor Transcription Pathway, Retinoic Acid Receptor Signaling Pathway, Steroid Hormone Mediated Signaling Pathway
Target
-